市场调查报告书
商品编码
1569494
眼科器材市场规模、份额和成长分析:按产品、按应用、按最终用途、按地区 - 行业预测,2024-2031 年Ophthalmology Devices Market Size, Share, Growth Analysis, By Product(Surgical & Vision Care), By Application(Cataract and Glaucoma), By End-user(Hospitals, Ophthalmic Clinics, Eye Clinics and Others), By Region - Industry Forecast 2024-2031 |
2022年全球眼科器材市场规模估值为283.3亿美元,从2023年的295.2亿美元增加至2031年的362.6亿美元,预测期间(2024-2031)预计复合年增长率为4.2%。
由于光学相干断层扫描(OCT)和眼底成像等诊断影像技术的进步,提高了眼科疾病的灵敏度和早期检测能力,预计眼科诊断设备市场将显着成长。除了这些技术进步之外,诸如微切口白内障手术(MICS)和雷射辅助屈光等微创手术技术的趋势也在不断增长,而市场对提高准确性、安全性和缩短恢復时间的需求也在增加。此外,医疗保健支出的增加,特别是在新兴经济体,正在推动先进眼科技术和程序的采用,但上市时间和合遵循成本方面仍然存在挑战。全球人口老化的人口变化,预计2022年65岁以上人口将达到7.71亿,2050年将增至16亿,这也是推动市场成长的一个极为重要的因素。老年人数量迅速增加,特别是在非洲和拉丁美洲等地区,与患有各种疾病(包括心血管疾病)的风险增加有关。这些人口趋势代表了眼科设备领域的重大市场机会,因为医疗保健系统越来越注重提供先进的诊断和治疗,以满足人口老化的需求。因此,技术创新、外科手术进步和人口变化的结合为眼科诊断设备产业的成长提供了强劲的前景。
Global Ophthalmology Devices Market size was valued at USD 28.33 Billion in 2022 and is poised to grow from USD 29.52 Billion in 2023 to USD 36.26 Billion by 2031, growing at a CAGR of 4.2% in the forecast period (2024-2031).
The ophthalmic diagnostic devices market is poised for significant growth driven by ongoing advancements in imaging technologies like Optical Coherence Tomography (OCT) and fundus imaging, enhancing the sensitivity and early detection of ocular diseases. This technological progress is coupled with the rising trend toward minimally invasive surgical techniques, such as microincision cataract surgery (MICS) and laser-assisted refraction procedures, known for their improved accuracy, safety, and quicker recovery times, which further fuels market demand. Additionally, growing healthcare expenditures, particularly in emerging economies, are facilitating the adoption of sophisticated ophthalmic technologies and procedures, although challenges related to time to market and compliance costs remain. The demographic shift towards an aging global population, projected to reach 771 million individuals aged 65 and older by 2022, with numbers expected to escalate to 1.6 billion by 2050, is another pivotal factor driving market growth. The rapid increase of elderly individuals, particularly in regions such as Africa and Latin America, correlates with a heightened risk of developing various diseases, including cardiovascular ailments. This demographic trend underscores a significant market opportunity within the ophthalmic devices sector, as healthcare systems increasingly focus on providing advanced diagnostics and treatments to address the needs of an aging population. Thus, the combination of technological innovations, surgical advancements, and demographic shifts suggests a robust landscape for growth in the ophthalmic diagnostic devices sector.
Top-down and bottom-up approaches were used to estimate and validate the size of the global ophthalmology devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
global ophthalmology devices Market Segmental Analysis
Based on the product, the ophthalmology devices market is segmented into surgical & vision care. By application the ophthalmology devices market is segmented into cataract and glaucoma. Based on the end-user, the global market is segmented into hospitals, ophthalmic clinics, eye clinics and others. Geographically, the global ophthalmology devices market has been segmented into Asia-Pacific, North America, Europe, and the Middle East & Africa, and Latin America.
Driver of the global ophthalmology devices Market
The rising incidence of eye infections and related discomfort is a significant driver for the global ophthalmology devices market. With an increase in pollution levels and the prevalence of irritants-such as smoke, dust, and harsh cosmetics-the demand for reliable diagnostic and therapeutic ophthalmology devices is surging. Conditions like blepharitis and dry eyes further exacerbate the need for effective interventions. Moreover, growing awareness of ocular health and continuous advancements in the pharmaceutical sector enhance the urgency for innovative ophthalmic devices, thereby increasing market growth. As eye health becomes a priority for consumers and healthcare providers alike, the market is poised for expansion.
Restraints in the global ophthalmology devices Market
The global ophthalmology devices market faces significant restraints due to several factors prevalent in emerging countries. A decrease in per capita healthcare expenditure hampers the ability to invest in advanced ophthalmic treatments and technologies. Additionally, limited product accessibility restricts the distribution and adoption of innovative devices, further impeding patient care. Compounding these challenges is a lack of awareness regarding ophthalmic diseases, leading to a lower number of patients seeking necessary treatments. For instance, disparities in surgical rates, such as the cataract surgery procedures observed in China compared to the U.S., illustrate the existing limitations that hinder market growth in these regions.
Market Trends of the global ophthalmology devices Market
The global ophthalmology devices market is experiencing robust growth, driven by the increasing demand for innovative equipment, accessories, and contact lenses among healthcare professionals and patients. Notably, advancements such as micro-invasive glaucoma surgeries (MIGs) have emerged as a rapidly growing segment, catering to the treatment needs for mild to moderate glaucoma. Furthermore, market players are directing their efforts toward developing advanced micro-invasive cataract surgical implants, which are expected to enhance surgical outcomes and patient satisfaction. This trend highlights a shift toward less invasive procedures, ultimately propelling the expansion of the ophthalmic devices market in the coming years.